NuvoAir is pioneering the transformation of cardiopulmonary care through its innovative approach to healthcare delivery, merging technology with patient-centered solutions. Founded in 2016 by Lorenzo Consoli, the company addresses a critical gap in chronic condition management, focusing particularly on complex conditions such as asthma, COPD, and heart failure. NuvoAir’s approach is built on the understanding that effective care requires more than traditional in-person visits; it demands a proactive, continuous relationship between patients and their healthcare providers. This leads to better outcomes and lower healthcare costs by preventing exacerbations.
The core of NuvoAir's service is its virtual-first care model, which empowers patients to receive timely support wherever they are. Patients have access to personalized care plans that utilize easy-to-use devices for monitoring health metrics such as lung function and oxygen levels. This not only enhances patient engagement but allows healthcare providers to respond swiftly to any health changes. As the company continues to grow, the goal remains clear: to ensure that no patient is left behind, providing accessible, high-quality care that transforms lives and improves health outcomes.
United States only